ARCHIVES

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 23 | June 18, 2010

Download PDF Visit The Full Archive

Related Articles

AACR Grant Programs. NIH RFA Available.

June 29, 2001

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

December 28, 2012

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976

In Brief: Wilson Names Director, MCW cancer Center; UAB Cancer Center Makes Three Appointments

February 9, 1996

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

Small Businesses Receive $18 Million From NCI Through SBIR Program

July 31, 1992